SCS-0775258-3/10003/1

Abbvie Corporation — FEI 3010173015

Refusal Details

Date
January 14, 2026
Country
Canada
Product Category
Drugs and Biologics
Product Code
58MCY09 RISANKIZUMAB-RZAA
Charges
75